The comparison between CJC-1295 with DAC and CJC-1295 without DAC is one of the most important methodological distinctions in growth hormone secretagogue research. The two compounds share the same core peptide sequence but differ in one critical chemical feature: the presence or absence of the drug affinity complex modification. That single feature changes the pharmacokinetic profile dramatically, and the choice between the two variants determines what kind of research study is practical. This companion to the CJC-1295 / Ipamorelin Blend: What Researchers Need to Know reviews the comparison in depth and connects it to the broader literature on growth hormone releasing peptides.
CJC-1295 With DAC vs No DAC: Extended Half-Life Research Comparison
CJC-1295 / Ipamorelin · Published April 14, 2026 · Updated May 18, 2026 · 9 min read
Quick Answer
CJC-1295 With DAC and No DAC differ in half-life and pulsatility because DAC adds an albumin-binding moiety that extends duration. This comparison covers pharmacokinetic differences, pulsatile versus sustained GH release, and how each form fits different research questions. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
- The Chemistry Behind the DAC Modification
- Pharmacokinetic Consequences for Research Design
- Research Applications of CJC-1295 No DAC
- Research Applications of CJC-1295 DAC
- Downstream Signaling Comparison
- Analytical Considerations for DAC and No DAC
- Comparison to Tesamorelin as a GHRH Analog
- Research Peptides Referenced
- Related Research Reading
- Related Research Articles
- Explore Related Products
- Frequently Asked Questions
- Glossary
Frequently Asked Questions
What is CJC-1295 in research contexts?
+
CJC-1295 is a synthetic 30-amino-acid analog of growth hormone-releasing hormone (GHRH). It is studied in research models as a long-acting GHRH receptor agonist that drives pulsatile growth hormone release from the pituitary.
What is the practical difference between CJC-1295 with DAC and no DAC?
+
With DAC, the maleimidopropionic acid linker binds serum albumin covalently, extending half-life from minutes to about 8 days. No DAC retains DPP-IV resistance but lacks albumin binding, producing a half-life of approximately 30 minutes and discrete pulse-like GH release.
Which form is preferred for which research questions?
+
The DAC form is preferred when sustained GHRH signaling is desired (chronic IGF-1 elevation studies). The no-DAC form is preferred when discrete pulsatile GH release is the desired endpoint, as in nocturnal pulse amplification or pulse architecture research.
Is CJC-1295 approved for human use?
+
No. CJC-1295 is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.
Glossary
Key terms used in this article.
- GHRH
- Growth hormone-releasing hormone, the hypothalamic peptide that stimulates pituitary growth hormone release.
- DAC (Drug Affinity Complex)
- A maleimidopropionic acid linker on CJC-1295 that covalently binds serum albumin to extend half-life.
- Pulsatile Release
- The episodic, rhythmic secretion pattern characteristic of growth hormone from the anterior pituitary.
- Pituitary Somatotroph
- The anterior pituitary cell type that synthesizes and secretes growth hormone.
- IGF-1
- Insulin-like growth factor 1, the primary downstream mediator of growth hormone action, produced largely in the liver.
- Albumin Binding
- Reversible or covalent binding to serum albumin that prolongs plasma half-life by reducing renal filtration and proteolysis.
- Cysteine-34
- The reactive cysteine residue on serum albumin that covalently binds the maleimide linker on DAC-modified CJC-1295.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
